| Identification | Back Directory | [Name]
3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine | [CAS]
641571-16-6 | [Synonyms]
3-(5-methylimidazol-1-yl)-5-(trifluoromethyl)aniline
3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)aniline
3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine
Benzenamine, 3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)- | [Molecular Formula]
C11H10F3N3 | [MDL Number]
MFCD28127256 | [MOL File]
641571-16-6.mol | [Molecular Weight]
241.212 |
| Chemical Properties | Back Directory | [Melting point ]
131-133oC | [storage temp. ]
Hygroscopic, Refrigerator, under inert atmosphere | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [color ]
White to Pale Red | [Stability:]
Air Sensitive |
| Hazard Information | Back Directory | [Uses]
3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine is used in the preparation of c-Src and Abl inhibitors based on the scaffold present in Imatinib (G407000), used in the treatment of myelogenic leukemia. | [Uses]
3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine is used in the preparation of c-Src and Abl inhibitors based on the scaffold present in Imatinib (G407000), used in the treatment of myelogenic leukemia. It is a COVID19-related research product. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
|